GENEVA, March 19 -- ADDITION THERAPEUTICS, INC. (201 Haskins Way, Suite 300South San Francisco, California 94080) filed a patent application (PCT/US2025/044479) for "COMPOSITIONS FOR TARGET PRIMED REVERSE TRANSCRIPTION" on Sep 02, 2025. With publication no. WO/2026/055129, the details related to the patent application was published on Mar 12, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): VENKATARAMANAN, Srivats (201 Haskins Way, Suite 300South San Francisco, California 94080)
Abstract: Provided herein are nucleic acid constructs and systems for target primed reverse transcription gene ins...